ArticleCurrent pharmacogenomics and personalized medicine2011

Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.

Michel C F Shamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.